These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9197375)
1. Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: clues from the Fourth Conference on Retroviruses and Opportunistic Diseases. Schnittman SM; Fox L AIDS Res Hum Retroviruses; 1997 Jul; 13(10):815-8. PubMed ID: 9197375 [TBL] [Abstract][Full Text] [Related]
2. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals. Mojumdar K; Vajpayee M; Chauhan NK; Singh A; Singh R; Kurapati S Cytometry B Clin Cytom; 2012 Jan; 82(1):43-53. PubMed ID: 21695776 [TBL] [Abstract][Full Text] [Related]
3. Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. Dyer WB; Kuipers H; Coolen MW; Geczy AF; Forrester J; Workman C; Sullivan JS AIDS Res Hum Retroviruses; 2002 Sep; 18(14):999-1010. PubMed ID: 12396452 [TBL] [Abstract][Full Text] [Related]
4. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM; Schapiro JM; Winters MA; Merigan TC AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710 [TBL] [Abstract][Full Text] [Related]
5. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. Benito JM; López M; Lozano S; González-Lahoz J; Soriano V J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371 [TBL] [Abstract][Full Text] [Related]
7. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir. Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072 [TBL] [Abstract][Full Text] [Related]
8. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887 [TBL] [Abstract][Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
10. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575 [TBL] [Abstract][Full Text] [Related]
11. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Pierson T; McArthur J; Siliciano RF Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072 [TBL] [Abstract][Full Text] [Related]
13. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection. Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207 [TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses. Blazevic V; Jankelevich S; Steinberg SM; Jacobsen F; Yarchoan R; Shearer GM Clin Diagn Lab Immunol; 2001 Sep; 8(5):943-8. PubMed ID: 11527808 [TBL] [Abstract][Full Text] [Related]
15. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy. Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM; AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422 [TBL] [Abstract][Full Text] [Related]
16. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)]. Panel de expertos de GeSIDA y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461 [TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy. Connick E J Investig Dermatol Symp Proc; 2001 Dec; 6(3):212-8. PubMed ID: 11924830 [TBL] [Abstract][Full Text] [Related]
18. Themes: the IVth Conference on Human Retroviruses and Opportunistic Infections. PI Perspect; 1997 Mar; (No 21):1-4. PubMed ID: 11364205 [TBL] [Abstract][Full Text] [Related]
19. The value of preserving HIV-specific immune responses. Kaufmann DE; Rosenberg ES J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711 [TBL] [Abstract][Full Text] [Related]
20. T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity. Pulido I; Machmach K; Romero-Sánchez MC; Genebat M; Mendez-Lagares G; Ruiz-Mateos E; Leal M J Infect; 2012 Apr; 64(4):417-23. PubMed ID: 22227467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]